Finweek - English

Simon’s stock tips

SASOL

A gut kick

asol’s interim results through 31 December were worse than expected, even as management called it “satisfactory”. That’s a gut kick to shareholders; some sense as to the destruction of the share price wouldn’t be amiss. Debt is higher than the market cap, so dividends were skipped and won’t be back soon. More pain was the downgrade of their debt by Moody’s (S&P kept its rating unchanged). In the immediate it’s moot, but as debt rolls over they’ll potentially pay higher costs. OPEC’s attempt in early March to get Russia to cut production failed, so Saudi Arabia (via oil company Saudi Aramco) started an oil war with Russia, selling oil at up to $10 under the market price. On 9 March oil fell 30% and Sasol

You’re reading a preview, subscribe to read more.

More from Finweek - English

Finweek - English3 min read
Keep On Keeping It Simple
recently I had a Covid-19-compliant coffee with some investors who’d started investing around ten years ago. We were chatting about stocks, market crashes and the like but then the conversation took an interesting turn. I asked what they believed to
Finweek - English1 min read
Construction Picks Up Pace
BUY SELL HOLD Back in May, I recommended construction firm Raubex as a buy – it has gained about 20% since then. The company released solid results for the six months through 31 August on 8 November. Revenue jumped 52% compared to the same period a y
Finweek - English2 min read
Healthy Results
BUY SELL HOLD Private healthcare group Mediclinic International’s profits more than tripled for the six months through 30 September, almost reaching pre-pandemic levels. Mediclinic, which is based in London and has hospitals in Southern Africa, Europ

Related Books & Audiobooks